Skip to search formSkip to main contentSkip to account menu

Recombinant MAGE-3.1 Antigen

Known as: MAGE-3, MAGE-3.1, MAGEA3 
A recombinant tumor-specific melanoma antigen. Vaccination with recombinant MAGE-3.1 antigen may induce a host immune response against MAGE… 
National Institutes of Health

Related topics

Related topics

4 relations
MAGEA3 geneMAGEA3 protein, humanMAGEA3 wt AlleleNCIt Antineoplastic Agent Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Poster Session
Introduction: Cancer testis antigens (CTAs) are an expanding family of immunogenic genes which provide attractive targets for… 
2015
2015
Abstract 2507: Bivalent adenylate cyclase (CYA)-based therapeutic vaccines: eradication of tumor cells expressing different antigens over time
Introduction: ProCervix is a clinical stage HPV16 E7/HPV18 E7 bivalent adenylate cyclase (CyaA)-based therapeutic vaccine… 
Review
2014
Review
2014
MAGEA3 (melanoma antigen family A, 3)
In the year 1991 Van der Bruggen P et al. cloned and named MAGE-1 gene that encodes MZ2E antigen, which is expressed in melanoma… 
2008
2008
Are vaccines making a comeback in non-small-cell lung cancer?
For decades we have investigated immune-based therapies in other types of cancer, namely melanoma, prostate, renal cell… 
2005
2005
Jump-starting tumor-specific T cells
Vaccination with tumor antigens causes tumor regression in some melanoma patients despite negligible expansion of vaccine… 
2005
2005
Rethinking EAE pathogenesis
Vaccination with tumor antigens causes tumor regression in some melanoma patients despite negligible expansion of vaccine… 
2003
2003
Vaccine-induced CD 8 T-cell Responses to MAGE-3 Correlate with Clinical Outcome in Patients with Melanoma 1
Purpose: Vaccine-induced antitumor CD8 T-cell responses are believed to play an important role in increasing resistance to… 
1999
1999
Verminderte Progressionsrate und Induktion tumorspezifischer Immunantworten durch adjuvante Immuntherapie bei Stadium-IV-Melanomen
ZusammenfassungDas Melanom im Stadium der Fernmetastasierung (Stad. IV) ist auch heute noch eine Erkrankung mit in aller Regel… 
1997
1997
Stimulation of CD8+T cell responses to MAGE-3 and MART-1 by a shed, polyvalent melanoma antigen vaccine: 031
1994
1994
coding for the precursor of the responsible for the tumorabstossung antigens mage-3, isolated nucleic acid molecule and its use